Previous evidence has suggested a role for calmodulin (CaM) in opioid recep
tor signaling. We demonstrate here that morphine stimulation of the mu-opio
id (OP3) receptor causes rapid CaM translocation to the nucleus in OP3-tran
sfected human embryonic kidney (HEK)-293 cells and in SH-SY5Y human neurobl
astoma cells. Ca2+ influx into the cells resulting from OP3 receptor activa
tion was required for nuclear CaM translocation. Moreover, in HEK-OP3 and S
H-SY5Y cells, increased nuclear CaM content was associated with enhanced ph
osphorylation of the nuclear transcription factor cyclic AMP-responsive ele
ment-binding protein. This appeared to be mediated by Ca2+/CaM kinases and
also by a pathway involving protein kinase C. CaM was previously shown to b
ind directly to the OP3 receptor and to be released from the plasma membran
e on agonist stimulation. To test whether OP3-mediated CaM release contribu
tes to nuclear CaM signaling, we used a mutant OP3 receptor (K273A) with re
duced affinity for CaM that fails to release CaM from the plasma membrane.
K273A-OP3 activated Ca2+ influx to a similar extent as wild-type OP3; howev
er, CaM translocation to the nucleus was attenuated. These results indicate
that OP3-stimulated Ca2+ influx results in nuclear CaM translocation, whic
h appears to be enhanced by simultaneous CaM release by OP3 wild-type recep
tor from plasma membranes. These results suggest a novel Ca2+/CaM signaling
pathway of opioid receptors in the regulation of transcriptional activity.